Author:
Denstaedt Scott J.,Singer Benjamin H.,Standiford Theodore J.
Funder
National Institutes of Health
Subject
Immunology,Immunology and Allergy
Reference167 articles.
1. Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome;Abraham;J Am Med Assoc.,1995
2. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial;Dhainaut;Crit. Care Med.,1994
3. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome;Fisher;JAMA,1994
4. Sir Isaac Newton, sepsis, SIRS, and CARS;Bone;Crit Care Med.,1996
5. Assessment of global incidence and mortality of hospital-treated sepsis current estimates and limitations;Fleischmann;Am J Respir Crit Care Med.,2016